US extends review of Roche MS drug Ocrevus by three months
Posted: Fri Dec 23, 2016 2:39 am
The U.S. Food and Drug Administration (FDA) has extended its review of Roche's multiple sclerosis drug Ocrevus by three months to March 28, the Swiss drugmaker said recently...Read more - http://www.ms-uk.org/us-extends-review- ... ths-231216